Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key MetricsZacks Investment Research • 04/22/24
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.Market Watch • 04/16/24
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical TrialsBusiness Wire • 04/16/24
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trialBusiness Wire • 04/16/24
Astrazeneca (AZN) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 04/11/24
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its BoardAccesswire • 04/10/24
Meet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.Barrons • 04/09/24